Title | Type | SJR | H index | Total Docs. (2014) | Total Docs. (3years) | Total Refs. (2014) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2014) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
34 | Open Biomarkers Journal | journal | 0.147 Q4 | 7 | 0 | 9 | 0 | 4 | 9 | 0.60 | 0.00 | |
33 | Current Signal Transduction Therapy | journal | 0.154 Q4 | 22 | 23 | 115 | 1439 | 43 | 103 | 0.51 | 62.57 | |
32 | Open Biotechnology Journal | journal | 0.159 Q4 | 18 | 3 | 14 | 22 | 6 | 14 | 0.44 | 7.33 | |
31 | Current Angiogenesis | journal | 0.178 Q4 | 6 | 18 | 45 | 1026 | 18 | 42 | 0.40 | 57.00 | |
30 | Current Cancer Therapy Reviews | journal | 0.200 Q4 | 17 | 29 | 93 | 1768 | 46 | 87 | 0.31 | 60.97 | |
29 | Current Enzyme Inhibition | journal | 0.212 Q4 | 19 | 16 | 55 | 683 | 27 | 49 | 0.43 | 42.69 | |
28 | Current Pharmacogenomics and Personalized Medicine | journal | 0.220 Q4 | 20 | 16 | 109 | 867 | 84 | 86 | 0.62 | 54.19 | |
27 | Letters in Organic Chemistry | journal | 0.231 Q4 | 33 | 121 | 401 | 3717 | 270 | 398 | 0.72 | 30.72 | |
26 | Letters in Drug Design and Discovery | journal | 0.241 Q4 | 37 | 135 | 392 | 4348 | 303 | 387 | 0.85 | 32.21 | |
25 | Current Pharmaceutical Analysis | journal | 0.243 Q4 | 27 | 36 | 129 | 1263 | 102 | 127 | 0.82 | 35.08 | |
24 | Current Proteomics | journal | 0.251 Q4 | 27 | 34 | 87 | 2446 | 54 | 79 | 0.64 | 71.94 | |
23 | Drug Metabolism Letters | journal | 0.306 Q3 | 31 | 17 | 92 | 483 | 97 | 90 | 0.91 | 28.41 | |
22 | Current Bioinformatics | journal | 0.320 Q4 | 38 | 60 | 158 | 2791 | 162 | 144 | 1.05 | 46.52 | |
21 | Current Chemical Biology | journal | 0.320 Q3 | 26 | 11 | 78 | 731 | 74 | 71 | 1.17 | 66.45 | |
20 | Current Nanoscience | journal | 0.350 Q3 | 52 | 136 | 397 | 3897 | 499 | 388 | 1.19 | 28.65 | |
19 | Current Computer-Aided Drug Design | journal | 0.380 Q4 | 32 | 36 | 113 | 1849 | 172 | 101 | 1.21 | 51.36 | |
18 | Recent Patents on Biotechnology | journal | 0.385 Q3 | 42 | 21 | 62 | 1430 | 92 | 57 | 1.40 | 68.10 | |
17 | Current Organic Synthesis | journal | 0.537 Q3 | 55 | 59 | 170 | 5092 | 405 | 159 | 2.16 | 86.31 | |
16 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.660 Q3 | 45 | 33 | 67 | 2056 | 110 | 62 | 1.78 | 62.30 | |
15 | Current Aging Science | journal | 0.663 Q3 | 42 | 20 | 101 | 1290 | 232 | 98 | 1.82 | 64.50 | |
14 | Open Medicinal Chemistry Journal | journal | 0.743 Q3 | 23 | 4 | 24 | 233 | 78 | 23 | 1.45 | 58.25 | |
13 | Mini-Reviews in Medicinal Chemistry | journal | 0.769 | 107 | 95 | 412 | 8756 | 1381 | 393 | 3.20 | 92.17 | |
12 | Infectious Disorders - Drug Targets | journal | 0.808 Q3 | 61 | 33 | 133 | 1828 | 251 | 120 | 1.72 | 55.39 | |
11 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.895 Q3 | 39 | 15 | 88 | 1044 | 212 | 79 | 2.35 | 69.60 | |
10 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.963 Q2 | 108 | 144 | 409 | 11251 | 1144 | 375 | 2.65 | 78.13 | |
9 | Recent Patents on Anti-Cancer Drug Discovery | journal | 1.092 Q2 | 52 | 22 | 81 | 3347 | 270 | 74 | 4.46 | 152.14 | |
8 | Current Diabetes Reviews | journal | 1.200 Q2 | 68 | 41 | 145 | 3375 | 556 | 142 | 3.76 | 82.32 | |
7 | Current Medicinal Chemistry | journal | 1.282 Q2 | 202 | 322 | 1293 | 39596 | 5384 | 1224 | 4.11 | 122.97 | |
6 | Current Drug Targets | journal | 1.395 Q1 | 119 | 118 | 561 | 12855 | 1973 | 508 | 3.19 | 108.94 | |
5 | Current Molecular Pharmacology | journal | 1.419 Q2 | 49 | 18 | 77 | 1656 | 261 | 69 | 2.78 | 92.00 | |
4 | Current Genomics | journal | 1.477 Q2 | 77 | 47 | 182 | 3980 | 683 | 166 | 2.69 | 84.68 | |
3 | Current Gene Therapy | journal | 1.503 Q2 | 80 | 45 | 141 | 3701 | 509 | 127 | 2.86 | 82.24 | |
2 | Current Cancer Drug Targets | journal | 1.533 Q2 | 103 | 65 | 265 | 6080 | 1029 | 246 | 3.86 | 93.54 | |
1 | Current Protein and Peptide Science | journal | 1.545 Q1 | 96 | 74 | 224 | 7495 | 685 | 202 | 3.36 | 101.28 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®